MicroRNA let-7c regulates macrophage polarization

Journal of Immunology

Volumn 190, Issue 12, 2013, Pages 6542-6549

  Banerjee, Sami ^a   Xie, Na ^a   Cui, Huachun ^a   Tan, Zheng ^a   Yang, Shanzhong ^a   Icyuz, Mert ^a   Abraham, Edward ^b   Liu, Gang ^a  

^a University of Alabama at Birmingham   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN DELTA; INTERLEUKIN 12; INTERLEUKIN 4; MICRORNA; MICRORNA LET 7C; STAT6 PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPRESSED SEQUENCE TAG; GENE OVEREXPRESSION; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG LAVAGE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PHASE TRANSITION; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL POLARITY; FLOW CYTOMETRY; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICRORNAS; PHENOTYPE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 84879118942     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202496     Document Type: Article

References (60)

1. Lawrence, T., and G. Natoli. 2011. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11: 750-761.
2. Murray, P. J., and T. A. Wynn. 2011. Obstacles and opportunities for understanding macrophage polarization. J. Leukoc. Biol. 89: 557-563.
3. Liu, G., and E. Abraham. 2013. MicroRNAs in immune response and macrophage polarization. Arterioscler. Thromb. Vasc. Biol. 33: 170-177.
4. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8: 958-969.
5. Martinez, F. O., S. Gordon, M. Locati, and A. Mantovani. 2006. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177: 7303-7311. (Pubitemid 44715100)
6. Satoh, T., O. Takeuchi, A. Vandenbon, K. Yasuda, Y. Tanaka, Y. Kumagai, T. Miyake, K. Matsushita, T. Okazaki, T. Saitoh, et al. 2010. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 11: 936-944.
7. Krausgruber, T., K. Blazek, T. Smallie, S. Alzabin, H. Lockstone, N. Sahgal, T. Hussell, M. Feldmann, and I. A. Udalova. 2011. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol. 12: 231-238.
8. Fleetwood, A. J., T. Lawrence, J. A. Hamilton, and A. D. Cook. 2007. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J. Immunol. 178: 5245-5252. (Pubitemid 46595309)
9. Verreck, F. A., T. de Boer, D. M. Langenberg, M. A. Hoeve, M. Kramer, E. Vaisberg, R. Kastelein, A. Kolk, R. de Waal-Malefyt, and T. H. Ottenhoff. 2004. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. USA 101: 4560-4565. (Pubitemid 38437450)
10. Fleetwood, A. J., H. Dinh, A. D. Cook, P. J. Hertzog, and J. A. Hamilton. 2009. GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling. J. Leukoc. Biol. 86: 411-421.
11. Escribese, M. M., E. Sierra-Filardi, C. Nieto, R. Samaniego, C. Sánchez-Torres, T. Matsuyama, E. Calderon-Gómez, M. A. Vega, A. Salas, P. Sánchez-Mateos, and A. L. Corbí. 2012. The prolyl hydroxylase PHD3 identifies proinflammatory macrophages and its expression is regulated by activin A. J. Immunol. 189: 1946-1954.
12. Ruffell, B., N. I. Affara, and L. M. Coussens. 2012. Differential macrophage programming in the tumor microenvironment. Trends Immunol. 33: 119-126.
13. Takeuch, O., and S. Akira. 2011. Epigenetic control of macrophage polarization. Eur. J. Immunol. 41: 2490-2493.
14. Mullican, S. E., C. A. Gaddis, T. Alenghat, M. G. Nair, P. R. Giacomin, L. J. Everett, D. Feng, D. J. Steger, J. Schug, D. Artis, and M. A. Lazar. 2011. Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation. Genes Dev. 25: 2480-2488.
15. Stefani, G., and F. J. Slack. 2008. Small non-coding RNAs in animal development. Nat. Rev. Mol. Cell Biol. 9: 219-230. (Pubitemid 351301826)
16. Croce, C. M. 2009. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 10: 704-714.
17. Latronico, M. V., and G. Condorelli. 2009. MicroRNAs and cardiac pathology. Nat. Rev. Cardiol. 6: 419-429.
18. Pandey, A. K., P. Agarwal, K. Kaur, and M. Datta. 2009. MicroRNAs in diabetes: tiny players in big disease. Cell. Physiol. Biochem. 23: 221-232.
19. Thum, T., C. Gross, J. Fiedler, T. Fischer, S. Kissler, M. Bussen, P. Galuppo, S. Just, W. Rottbauer, S. Frantz, et al. 2008. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980-984.
20. Graff, J. W., A. M. Dickson, G. Clay, A. P. McCaffrey, and M. E. Wilson. 2012. Identifying functional microRNAs in macrophages with polarized phenotypes. J. Biol. Chem. 287: 21816-21825.
21. Banerjee, S., A. de Freitas, A. Friggeri, J. W. Zmijewski, G. Liu, and E. Abraham. 2011. Intracellular HMGB1 negatively regulates phagocytosis. J. Immunol. 187: 4686-4694.
22. Bystrom, J., I. Evans, J. Newson, M. Stables, I. Toor, N. van Rooijen, M. Crawford, P. Colville-Nash, S. Farrow, and D. W. Gilroy. 2008. Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. Blood 112: 4117-4127.
23. de Freitas, A., S. Banerjee, N. Xie, H. Cui, K. I. Davis, A. Friggeri, M. Fu, E. Abraham, and G. Liu. 2012. Identification of TLT2 as an engulfment receptor for apoptotic cells. J. Immunol. 188: 6381-6388.
24. Yang, S., S. Banerjee, A. de Freitas, Y. Y. Sanders, Q. Ding, S. Matalon, V. J. Thannickal, E. Abraham, and G. Liu. 2012. Participation of miR-200 in pulmonary fibrosis. Am. J. Pathol. 180: 484-493.
25. Gibbons, M. A., A. C. MacKinnon, P. Ramachandran, K. Dhaliwal, R. Duffin, A. T. Phythian-Adams, N. van Rooijen, C. Haslett, S. E. Howie, A. J. Simpson, et al. 2011. Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am. J. Respir. Crit. Care Med. 184: 569-581.
26. Jakubzick, C., E. S. Choi, B. H. Joshi, M. P. Keane, S. L. Kunkel, R. K. Puri, and C. M. Hogaboam. 2003. Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4- and IL-13-responsive cells. J. Immunol. 171: 2684-2693. (Pubitemid 37025582)
27. Prasse, A., D. V. Pechkovsky, G. B. Toews, W. Jungraithmayr, F. Kollert, T. Goldmann, E. Vollmer, J. Müller-Quernheim, and G. Zissel. 2006. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am. J. Respir. Crit. Care Med. 173: 781-792.
28. Baran, C. P., J. M. Opalek, S. McMaken, C. A. Newland, J. M. O'Brien, Jr., M. G. Hunter, B. D. Bringardner, M. M. Monick, D. R. Brigstock, P. C. Stromberg, et al. 2007. Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 176: 78-89. (Pubitemid 47048057)
29. Guth, A. M., W. J. Janssen, C. M. Bosio, E. C. Crouch, P. M. Henson, and S. W. Dow. 2009. Lung environment determines unique phenotype of alveolar macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 296: L936-L946.
30. Lacey, D. C., A. Achuthan, A. J. Fleetwood, H. Dinh, J. Roiniotis, G. M. Scholz, M. W. Chang, S. K. Beckman, A. D. Cook, and J. A. Hamilton. 2012. Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models. J. Immunol. 188: 5752-5765.
31. Liao, X., S. M. Haldar, Y. Lu, D. Jeyaraj, K. Paruchuri, M. Nahori, Y. Cui, K. H. Kaestner, and M. K. Jain. 2010. Krüppel-like factor 4 regulates pressure-induced cardiac hypertrophy. J. Mol. Cell. Cardiol. 49: 334-338.
32. Chaudhuri, A. A., A. Y. So, N. Sinha, W. S. Gibson, K. D. Taganov, R. M. O'Connell, and D. Baltimore. 2011. MicroRNA-125b potentiates macrophage activation. J. Immunol. 187: 5062-5068.
33. Zhuang, G., C. Meng, X. Guo, P. S. Cheruku, L. Shi, H. Xu, H. Li, G. Wang, A. R. Evans, S. Safe, et al. 2012. A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation 125: 2892-2903.
34. Puig-Kröger, A., E. Sierra-Filardi, A. Domínguez-Soto, R. Samaniego, M. T. Corcuera, F. Gómez-Aguado, M. Ratnam, P. Sánchez-Mateos and A. L. Corbí. 2009. Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages. Cancer Res. 69: 9395-9403.
35. Hou, W., Q. Tian, N. M. Steuerwald, L. W. Schrum, and H. L. Bonkovsky. 2012. The let-7 microRNA enhances heme oxygenase-1 by suppressing Bach1 and attenuates oxidant injury in human hepatocytes. Biochim. Biophys. Acta 1819: 1113-1122.
36. Sierra-Filardi, E., M. A. Vega, P. Sánchez-Mateos, A. L. Corbí, and A. Puig-Kröger. 2010. Heme Oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release. Immunobiology 215: 788-795.
37. O'Neill, L. A. 2008. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol. Rev. 226: 10-18.
38. Ishii, M., H. Wen, C. A. Corsa, T. Liu, A. L. Coelho, R. M. Allen, W. F. Carson, IV, K. A. Cavassani, X. Li, N. W. Lukacs, et al. 2009. Epigenetic regulation of the alternatively activated macrophage phenotype. Blood 114: 3244-3254.
39. Lu, Y. C., I. Kim, E. Lye, F. Shen, N. Suzuki, S. Suzuki, S. Gerondakis, S. Akira, S. L. Gaffen, W. C. Yeh, and P. S. Ohashi. 2009. Differential role for c-Rel and C/EBPbeta/delta in TLR-mediated induction of proinflammatory cytokines. J. Immunol. 182: 7212-7221.
40. Litvak, V., S. A. Ramsey, A. G. Rust, D. E. Zak, K. A. Kennedy, A. E. Lampano, M. Nykter, I. Shmulevich, and A. Aderem. 2009. Function of C/EBPdelta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals. Nat. Immunol. 10: 437-443.
41. Maitra, U., L. Gan, S. Chang, and L. Li. 2011. Low-dose endotoxin induces inflammation by selectively removing nuclear receptors and activating CCAAT/enhancer-binding protein d. J. Immunol. 186: 4467-4473.
42. Uderhardt, S., M. Herrmann, O. V. Oskolkova, S. Aschermann, W. Bicker, N. Ipseiz, K. Sarter, B. Frey, T. Rothe, R. Voll, et al. 2012. 12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance. Immunity 36: 834-846.
43. Park, S. Y., M. Y. Jung, S. J. Lee, K. B. Kang, A. Gratchev, V. Riabov, J. Kzhyshkowska, and I. S. Kim. 2009. Stabilin-1 mediates phosphatidylserine- dependent clearance of cell corpses in alternatively activated macrophages. J. Cell Sci. 122: 3365-3373.
44. Geissmann, F., M. G. Manz, S. Jung, M. H. Sieweke, M. Merad, and K. Ley. 2010. Development of monocytes, macrophages, and dendritic cells. Science 327: 656-661.
45. Gordon, S., and P. R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5: 953-964. (Pubitemid 41746764)
46. Fadok, V. A., M. L. Warner, D. L. Bratton, and P. M. Henson. 1998. CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3). J. Immunol. 161: 6250-6257. (Pubitemid 28535999)
47. O'Neill, L. A. 2006. How Toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 18: 3-9. (Pubitemid 43049641)
48. Ruffell, D., F. Mourkioti, A. Gambardella, P. Kirstetter, R. G. Lopez, N. Rosenthal, and C. Nerlov. 2009. A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc. Natl. Acad. Sci. USA 106: 17475-17480.
49. Chen, X. M., P. L. Splinter, S. P. O'Hara, and N. F. LaRusso. 2007. A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J. Biol. Chem. 282: 28929-28938.
50. Hu, G., R. Zhou, J. Liu, A. Y. Gong, A. N. Eischeid, J. W. Dittman, and X. M. Chen. 2009. MicroRNA-98 and let-7 confer cholangiocyte expression of cytokine-inducible Src homology 2-containing protein in response to microbial challenge. J. Immunol. 183: 1617-1624.
51. Reinhart, B. J., F. J. Slack, M. Basson, A. E. Pasquinelli, J. C. Bettinger, A. E. Rougvie, H. R. Horvitz, and G. Ruvkun. 2000. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403: 901-906. (Pubitemid 30130993)
52. Grishok, A., A. E. Pasquinelli, D. Conte, N. Li, S. Parrish, I. Ha, D. L. Baillie, A. Fire, G. Ruvkun, and C. C. Mello. 2001. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 106: 23-34. (Pubitemid 32709955)
53. Kim, S. J., P. K. Gregersen, and B. Diamond. 2013. Regulation of dendritic cell activation by microRNA let-7c and BLIMP1. J Clin Invest. pii: 64712.
54. Pottelberge, G. R., P. Mestdagh, K. R. Bracke, O. Thas, Y. M. Durme, G. F. Joos, J. Vandesompele, and G. G. Brusselle. 2011. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 183: 898-906.
55. Schulte, L. N., A. Eulalio, H. J. Mollenkopf, R. Reinhardt, and J. Vogel. 2011. Analysis of the host microRNA response to Salmonella uncovers the control of major cytokines by the let-7 family. EMBO J. 30: 1977-1989.
56. Iliopoulos, D., H. A. Hirsch, and K. Struhl. 2009. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139: 693-706.
57. Polikepahad, S., J. M. Knight, A. O. Naghavi, T. Oplt, C. J. Creighton, C. Shaw, A. L. Benham, J. Kim, B. Soibam, R. A. Harris, et al. 2010. Proinflammatory role for let-7 microRNAS in experimental asthma. J. Biol. Chem. 285: 30139-30149.
58. Androulidaki, A., D. Iliopoulos, A. Arranz, C. Doxaki, S. Schworer, V. Zacharioudaki, A. N. Margioris, P. N. Tsichlis, and C. Tsatsanis. 2009. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 31: 220-231.
59. Büssing, I., F. J. Slack, and H. Grosshans. 2008. let-7 microRNAs in development, stem cells and cancer. Trends Mol. Med. 14: 400-409.
60. Ponomarev, E. D., T. Veremeyko, N. Barteneva, A. M. Krichevsky, and H. L. Weiner. 2011. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-a-PU.1 pathway. Nat. Med. 17: 64-70.